Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
55.62%
↑ 462% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthAccelerating
Average
-15.38%
Historical baseline
PeriodValue
202555.62%
2024-32.90%
2023-35.22%
2022-19.40%
2021-57.82%
2020-7.84%
2019-6.36%
20181.99%
2017-43.93%
2016-7.90%